JPMorgan Chase & Co’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-24
| Closed | -$3 | – | 6635 |
|
|
2024
Q1 | $3 | Hold |
24
| – | – | ﹤0.01% | 6291 |
|
|
2023
Q4 | $3 | Hold |
24
| – | – | ﹤0.01% | 6424 |
|
|
2023
Q3 | $4 | Sell |
24
-660
| -96% | -$110 | ﹤0.01% | 6426 |
|
|
2023
Q2 | $2.13K | Buy |
684
+660
| +2,750% | +$2.06K | ﹤0.01% | 5420 |
|
|
2023
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 6201 |
|
|
2022
Q4 | $0 | Hold |
24
| – | – | ﹤0.01% | 6043 |
|
|
2022
Q3 | $0 | Hold |
24
| – | – | ﹤0.01% | 5915 |
|
|
2022
Q2 | $0 | Hold |
24
| – | – | ﹤0.01% | 5999 |
|
|
2022
Q1 | $0 | Hold |
24
| – | – | ﹤0.01% | 6029 |
|
|
2021
Q4 | $0 | Sell |
24
-27
| -53% | – | ﹤0.01% | 5978 |
|
|
2021
Q3 | $0 | Sell |
51
-35,922
| -100% | – | ﹤0.01% | 5821 |
|
|
2021
Q2 | $353K | Buy |
35,973
+12,319
| +52% | +$121K | ﹤0.01% | 4192 |
|
|
2021
Q1 | $209K | Buy |
23,654
+1,090
| +5% | +$9.63K | ﹤0.01% | 4434 |
|
|
2020
Q4 | $231K | Buy |
22,564
+16,332
| +262% | +$167K | ﹤0.01% | 4108 |
|
|
2020
Q3 | $54K | Sell |
6,232
-832
| -12% | -$7.21K | ﹤0.01% | 4264 |
|
|
2020
Q2 | $50K | Buy |
7,064
+4,236
| +150% | +$30K | ﹤0.01% | 4210 |
|
|
2020
Q1 | $27K | Buy |
2,828
+609
| +27% | +$5.81K | ﹤0.01% | 4293 |
|
|
2019
Q4 | $29K | Buy |
+2,219
| New | +$29K | ﹤0.01% | 4368 |
|